Grade: Pharmaceutical Grade

Factory Location: Bianjing Road East of embankment, 475000, Kaifeng City, Henan, China

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Contract Manufacturing: CMO

Sample Provided: no

Payment Terms: T/T

It is currently the only new type of aldose reductase (AR) inhibitor. By inhibiting the formation of sorbitol, it improves the subjective symptoms (numbness, pain) and abnormal nerve functions of diabetic peripheral neuropathy, and is used as a drug for the treatment of diabetic neuropathy.